4//SEC Filing
RAMALINGAM AJIT 4
Accession 0001062993-22-022078
CIK 0000012208other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 4:33 PM ET
Size
7.9 KB
Accession
0001062993-22-022078
Insider Transaction Report
Form 4
BIO-RAD LABORATORIES, INC.BIO BIOB
RAMALINGAM AJIT
SVP, Chief Accounting Officer
Transactions
- Sale
Bio-Rad A Common Stock
2022-11-10$421.70/sh−267$112,594→ 112.381 total - Sale
Bio-Rad A Common Stock
2022-11-10$422.28/sh−112$47,295→ 0.381 total - Sale
Bio-Rad A Common Stock
2022-11-10$423.61/sh−0.381$161→ 0 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $421.47 to $421.94, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]Includes 13.884 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2022.
Issuer
BIO-RAD LABORATORIES, INC.
CIK 0000012208
Entity typeother
Related Parties
1- filerCIK 0001807891
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 4:33 PM ET
- Size
- 7.9 KB